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Abstract: At low temperature and in the presence of an acid catalyst, SO2 adds to 1,3-dienes
equilibrating with the corresponding 3,6-dihydro-1,2-oxathiin-2-oxides (sultines). These
compounds are unstable above –60 °C and equilibrate with the more stable 2,5-dihydro-
thiophene 1,1-dioxides (sulfolenes). The hetero-Diels–Alder additions of SO2 are suprafacial
and follow the Alder endo rule. The sultines derived from 1-oxy-substituted and 1,3-dioxy-
disubstituted 1,3-dienes cannot be observed at –100 °C but are believed to be formed faster
than the corresponding sulfolenes. In the presence of acid catalysts, the 6-oxy-substituted
sultines equilibrate with zwitterionic species that react with electron-rich alkenes such as
enoxysilanes and allylsilanes, generating β,γ-unsaturated silyl sulfinates that can be desily-
lated and desulfinylated to generate polypropionate fragments containing up to three con-
tiguous stereogenic centers and an (E)-alkene unit. Alternatively, the silyl sulfinates can be
reacted with electrophiles to generate polyfunctional sulfones (one-pot, four-component syn-
thesis of sulfones), or oxidized into sulfonyl chlorides and reacted with amines, then realiz-
ing a one-pot, four-component synthesis of polyfunctional sulfonamides. Using enantio-
merically enriched dienes such as 1-[(R)- or 1-(S)-phenylethyloxy]-2-methyl-
(E,E)-penta-1,3-dien-3-yl isobutyrate, derived from inexpensive (R)- or (S)-1-phenylethanol,
enantiomerically enriched stereotriads are obtained in one-pot operations. The latter are
ready for further chain elongation. This has permitted the development of expeditious total
asymmetric syntheses of important natural products of biological interest such as the ba-
conipyrones, rifamycin S, and apoptolidin A. 
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INTRODUCTION
The organic chemistry of SO2 has been limited to the formation of arenesulfinic acids (Friedel–Crafts
sulfinylation [1,2]), the copolymerization of SO2 with alkenes or alkynes (polysulfone synthesis [3–5]),
the synthesis of sulfinates by reaction with organometallic compounds [6–8], the ring-opening of oxi-
ranes and oxetanes [8,9] leading to polysulfites [8,10–12], the synthesis of sulfones [8,13–15], the iso-
merization of alkenes via ene reaction/sigmatropic shift/retro-ene elimination sequence [16–22], and
the cheletropic additions of conjugated polyenes [23–25] forming cyclic sulfones, as the [ω2s+π4s] ad-
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dition of SO2 to isoprene producing 2,5-dihydro-3-methylthiophene-1,1-dioxide (sulfolene), a reaction
known since 1914 [26,27].
Other cycloadditions of SO2 have been described for the reaction of ketenes and ketimines
[28–31], cyclic polyenes [32–34], and quadricyclane [35]. Homocheletropic additions of SO2 to 1,4-di-
enes have been reported [36–38]. The first examples of hetero-Diels–Alder additions of SO2 involved
highly reactive dienes 1 [39] and 3 [40]. In 1992, we reported that simple 1,3-dienes undergo hetero-
Diels–Alder addition below –60 °C in the presence of a large excess of SO2 and of a protic or Lewis
acid promoter (Scheme 1). We showed that (E,E)-5-deuteropiperylene (6) equilibrates with sultine 7 at
–80 °C. At –60 °C, 7 is converted into the more stable isomeric sultine 8, thus demonstrating the
suprafaciability of the acid-catalyzed cycloaddition that obeys the Alder (endo) rule [41].
This led us to investigate the factors affecting the competition between the hetero-Diels–Alder
and the cheletropic addition of SO2. Our studies have been reviewed [42–45]. Apart from sultines re-
sulting from reactions of SO2 with 1-fluoro-1,3-dienes [46], sultines are less stable than their sulfolene
isomers. They decompose into the corresponding 1,3-dienes and SO2 above –50 °C [47–49]. With
1-alkoxy and 1-silyloxy-1,3-dienes 9, the sultines 10 are not seen at –100 °C as these dienes generate
the corresponding sulfolenes 11 at this temperature [50]. Nevertheless, sultines 10 are believed to be
formed before the sulfolenes. In the presence of an acid catalyst, they equilibrate with zwitterionic inter-
mediates 12 that can be reacted with electron-rich alkenes 13, thus realizing a new C–C bond-forming
reaction (Scheme 2) forming silyl sulfinates 14 [51,52].
In situ desilylation and stereoselective desulfination via retro-ene elimination of SO2 from theβ,γ-unsaturated sulfinic acids 14' [53–55] generates, in a one-pot operation, compounds 15 containing
up to three contiguous stereogenic centers and one (E)-alkene unit [52]. The polypropionate fragments
15 so-obtained have their two extremities ready for further chain elongation without requiring depro-
tection and activation. Alternatively, the intermediate sulfinates 14 can be converted in the same pot
into sulfones 16, thus realizing a one-pot, four-component synthesis of polyfunctional sulfones
[56–60]. In situ oxidation of sulfinates 14 with Cl2 or NCS provides the corresponding sulfonyl
chlorides that can be reacted with primary and secondary amines to provide the corresponding sulfon-
amides 17, thus realizing a one-pot, four-component synthesis of polyfunctional suflonamides [60,61].
We review here applications of our reaction cascade 9 + SO2 → 10 → 12 + 13 → 14 → 15 to the asym-
metric total synthesis of polypropionate antibiotics [62] and disclose further chemistry of sultines with
allylsilanes [63].
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Scheme 1 Examples of hetero-Diels–Alder additions of sulfur dioxide.
Synthesis of the cyclohexanone subunit of baconipyrones A and B and of the
hydroxydiketone subunit of baconipyrones C and D
Baconipyrones A–D (18–21) were isolated in 1989 by Faulkner and coworkers from Siphonaria ba-
coni [64]. They constitute an exception to the normal polypropionic skeleton with their noncontigu-
ous, ester-type backbone [65]. The first total synthesis of (–)-baconipyrone C was presented by
Paterson and coworkers [66] in 2000 [67]. Applying the “naked sugar” methodology [68–71], Plumet
and coworkers [72] obtained a 3,5-dihydroxycyclohexanone, which we showed happens to be a
stereoisomer of the cyclohexanone subunit 22 of baconipyrones A and B [73]. We have prepared 22
in only three steps (58 % overall yield) starting with the enantiomerically enriched diene 24 (derived
from 2-methyl-3-oxopentanal and inexpensive (S)-1-phenyl ethanol (97 % ee), in four steps, 61 %
overall yield, applying Danishefsky’s method [74,75]) and enoxysilanes 25 (derived from penta-3-
one). Thus, when a 1:2 mixtures of 24 + 25 is added to a 1:1 mixtures of SO2/toluene containing
0.25 equiv of Tf2NH cooled to –78 °C, a very intense yellow color appears (formation of diene⋅SO2
complex) which disappears after 24 h at –78 °C. After evaporation of the solvents (recovery of SO2),
the residue is treated with K2CO3 in i-PrOH/MeCN and heated to 80 °C in the presence of a catalyti-
cal amount of Pd(OAc)2 and Ph3P. This induces a stereoselective desulfinylation of the silyl sulfinate
intermediate 26 [76] with formation of 27 and 28 that are separated by flash chromatography on sil-
ica gel and isolated pure in 67 and 13 % yield, respectively (Scheme 3). Acidic treatment of 26 also
leads to desulfitation, but giving 27 and 28 in lower yields, probably because of the intrinsic instabil-
ity of these compounds under acidic conditions (elimination of phenylethanol, hydrolysis of
phenylethyl ether and retro-aldol, see below). Transesterification of enol ester 27 with Bu3SnOMe
[77,78] induces the desired stereoselective intramolecular aldol reaction (probably via 29 →← 29') and
furnishes 22 after quantitative debenzylation.
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Scheme 2 Reaction cascades via sultine ionization (umpolung with sulfur dioxide) permitting the one-pot
syntheses of polypropionate stereotriades, polyfunctional sulfones, and sulfonamides.
The high diastereoselectivity observed in the reaction of 24 → 27 + 28 (Scheme 3) can be inter-
preted in terms of a highly diastereoselective (suprafacial) hetero-Diels–Alder addition of SO2 to diene
24 in which the C–H bond of the phenylethyl ether resides in the π-plane of the cis-butadiene moiety
(Scheme 4). Thus, the SO2 coordinated to the Lewis acid promoter attacks the face of the diene syn with
respect to the methyl group of the phenylethyl ether group, giving sultine 30 that is ionized irreversibly
into zwitterion 31. There are two possible orientations, 32a and 32b, for the enoxysilane that command
the α,β-relative configuration in 33. As 27 is the major product, orientation 32a must be favored.
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Scheme 3 First total asymmetric synthesis of cyclohexanone subunit of baconipyrones A and B.
The Pd-catalyzed desulfination of silyl sulfinate 26 follows probably the mechanism proposed in
Scheme 5. Although we have no proof for it, studies with trimethylsilyl 2-methylprop-2-enesulfinate
have shown that Pd(OAc)2 alone in MeCN does not catalyze the reaction. The presence of Ph3P and
i-PrOH is crucial for success, and intermediacy of allyl-Pd species has been established [76]. The re-
markable chirality transfer 26 to 27 strongly supports a mechanism in which Pd(0) adds oxidatively (re-
tention of configuration) into the C–SO2SiMe3 bond of 26 producing 33. Subsequent desulfinylation
into 34 and protolysis of the Pd–SiMe3 bond giving i-PrOSiMe3 (driving force) is expected to generate
hydride 35 that undergoes regioselective and stereoselective β-insertion of hydride into the allyl-Pd
intermediate. An alternative mechanism is to invoke that the Pd(0) catalyst role is just to promote the
Si-sulfinate bond cleavage that generates the corresponding β,γ-unsaturated sulfinic acids that in turn
undergo classical retro-ene elimination of SO2 producing 27 [76]. Further studies are obviously neces-
sary for a better view. 
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Scheme 4 Face-selective hetero-Diels–Alder addition of SO2, stereoselective zwitterionic intermediate quenching
with enoxysilane.
Scheme 5 Possible mechanism for the Pd(0)-catalyzed desulfination of silyl sulfinates.
Enolization of ethylketone 27 with Et3SiOTf/NEt3 gives silyl enol ether 36 quantitatively
(Scheme 6). Treatment of 36 with MeLi provides 37 (90 %), which undergoes intramolecular
Mukaiyama aldol reaction promoted by BF3⋅Et2O giving a 9:1 mixture of 38 and 39, two stereoisomers
of 22. With Bu4NF in THF at –15 °C, 37 furnishes a 5:1 mixture of 38 and 39, whereas in CH2Cl2 at
–50 °C, a 1:3.5 mixture of 38 and 39 is formed in 76 % yield. Compounds 40 and 41 can be obtained
pure by flash chromatography on silica gel. Heating 37 with MeOH/NH4Cl to 130 °C provides dike-
tone 42 (41 %). Debenzylation gives the hydroxydiketone 23, subunit of baconipyrones C and D. These
transformations demonstrate the high efficiency and diversity of our synthetic approach to the poly-
propionate subunits of the baconipyrones and their stereomers.
Expeditious asymmetric synthesis of the stereoheptad C19–C27 of rifamycins: Formal
total synthesis of rifamycin S
Rifamycins [79–81] are antibiotics belonging to the group of naphthalenic ansamycins [82] character-
ized by an aliphatic bridge (polypropionate chain) linking two nonadjacent centers of an aromatic moi-
ety. They are produced from Streptomyces mediterranei [83] and are active against a large variety of or-
ganisms; including bacteria, eukaryotes, and viruses [84]. Rifamycins have shown also antitumor
[85–87] and anti-inflammatory activity [88], but at present are mainly used for the treatment of tuber-
culosis. Their antimicrobial activity is due to the inhibition of bacterial DNA-dependent RNA poly-
merase [89–92]. Several derivatives of rifamycin S (43) have been prepared, and many of them have
shown promising activities [93–96].
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Scheme 6 Synthesis of stereoisomeric 3,5-dihydroxycyclohexanones and of the hydroxydiketone subunit of
baconipyrones C and D.
The first total synthesis of rifamycin S was reported by Kishi and coworkers in 1980 (Fig. 1)
[97–100]. The stereoheptad 44 was a key intermediate for the construction of the ansa chain. It was ob-
tained in 26 steps and 5.2 % overall yield from (2S)-3-benzyloxy-2-methylpropanal (45). Since then,
several total asymmetric synthesis of 43 have been proposed [101–104], and the construction of the
C19–C27 fragment [(–)-44 and analogs] of this antibiotic has become a challenging target for the test-
ing of asymmetric synthetic methods and strategies [102,105–126]. Applying our reaction cascade
(Scheme 2), we have developed a synthesis of Kishi’s intermediate 44 in 25 % yield that requires the
isolation of only four synthetic intermediates (Scheme 6), starting from the readily available diene 24
(Scheme 3). The (Z)-enol ether 47 derived from ethyl ketone 27 (Scheme 3) reacts with 9-bromo-9-
borabicyclo[3.3.1]nonane (BrBBN) in CH2Cl2 (silyl/boron exchange) [172] and then with aldehyde 48
to produce a 12.5:1 mixture of 49 and 9-epimer in 81 % yield. Pure 49 is reduced under Evans’ condi-
tions [127] to give diol 50 (83 %), a stereoheptad equivalent to 44 of the asymmetric synthesis of rifa-
mycin S. The latter is derived from 50 (does not have to be purified) as shown in Scheme 7 [128].
Short synthesis of the C1–C11 and C16–C28 fragments of apoptolidinone: Formal total
synthesis of apoptolidin A
Apoptolidin A (51) isolated from Nocardiopsis sp [129,130], and natural analogs B (52) and D (54)
[131,132] are among the most interesting leads for cancer chemotherapy [133] as they induce apopto-
sis selectively in cancer cells (Fig. 2) [134–137].
© 2008 IUPAC, Pure and Applied Chemistry 80, 791–805
Use of sultines in the asymmetric synthesis 797
Fig. 1 Kishi’s retrosynthesis of rifamycin S.
Scheme 7 Expeditious asymmetric synthesis of a stereoheptad: formal total synthesis of rifamycin S.
Successful total synthesis of 1 has been achieved by the groups of Nicolaou [138–140] and Koert
[141,142]. Syntheses of apoptolidinone A, the aglycone of 1, were reported by the groups of
Sulikowsky [143], Crimmins [144], Nicolaou [138–140], and Koert [141,142]. In addition, several stud-
ies on the synthesis of fragments of apoptolidinones have been reported [137,145–155].
Applying our reaction cascade to diene 55 and enoxysilane 56, we have realized a rapid access
(9 steps) to Koert’s C16–C28 polyketide fragment 64 (Scheme 8) of apoptolidinones A and D [156]. This
fragment is adequately protected for the glycosidation steps necessary in the construction of 51.
P. VOGEL et al.
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Fig. 2 Structures of apoptolidins.
Scheme 8 Synthesis of Koert’s C16–C28 polyketide fragment.
The enantiomerically enriched (97 % ee) diene 55 [59] [derived from inexpensive (R)-1-
phenylethanol] and silyl ethers 56 (1:1 E/Z mixture) are reacted with (CF3SO2)2NH in SO2/CH2Cl2
(5:1) cooled to –78 °C. Solvent evaporation, alcoholysis with i-PrOH (80 °C), gives a 4:1 mixture of
stereotriade 57 and its α,β,γ-anti,anti stereomer. This mixture is converted into their kinetic silyl enol
ethers and oxidized with mCPBA (Rubottom oxidation [157]), giving 58, which undergoes Mukaiyama
aldol coupling with aldehyde 59 [158–160] producing alkene 60 (73 %). Ozonolysis of 60 provides an
aldehyde that is allylated under Brown’s conditions [161]. The resulting homoallylic alcohol is equili-
brated with the hemiacetal 61, which undergoes desilylation, hydrolysis of the 1-phenylethyl ether, and
Fischer glycosidation on treatment with HCl/MeOH at 50 °C. The resulting triol is then acetylated se-
lectively into diacetate 62 (Ac2O/pyridine, 0–20 °C). After silylation of 62 into 63, Sharpless asym-
metric dihydroxylation [162] furnishes a 4.5:1 mixture of the corresponding diol that is selectively
monomethylated with MeI/Ag2O giving the Koert’s 64 (68 %, after purification by flash column
chromatography on silica gel).
Another key intermediate in the total synthesis of apoptolidin A is the Nicolaou’s C1–C11 frag-
ment 69 [140]. We have developed an expeditious synthesis of 69 that requires the isolation of only
three synthetic intermediates (Scheme 9) [163] and is based on our one-pot, four-component synthesis
of sulfones. The combination of enoxysilanes 56, diene 65, SO2, and iodide 66 provides, after acidic
work-up (induced elimination of the β-silyloxy moiety), the (E,E)-dienone 67. Silyl ether and enol silyl
ether formation is followed by oxidation with mCPBA. This generates an α-hydroxyketone which is not
isolated but directly submitted to the Malaprade oxidation giving a carboxylic acid that is esterified in
situ with diazomethane producing 68 (1:1 mixture of diastereomers). Dess–Martin oxidation of the pri-
mary alcohol 68 gives an aldehyde that is reacted, without purification, with Me3SiC≡C–Li to give a
5:1 mixture of propargylic alcohols. They are silylated, and the sulfone moiety undergoes a
Ramberg–Bäcklund rearrangement providing a 12:1 mixture of (E,E,E)-(E,E,Z)-triene-ester 69 (99 %
ee) [164–166].
Synthesis of long-chain polyketide fragments using allylsilanes
When 1-oxy-1,3-dienes are mixed with allylsilanes and SO2 in the presence of an acid catalyst, only
products of ene reaction of the allylsilanes are observed. In contrast, when using 1,3-dioxy-1,3-dienes,
the hetero-Diels–Alder of SO2 with the latter can be faster than the ene-reaction cascade (hetero-
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Scheme 9 Expeditious synthesis of the Nicolaou’s C1–C11 fragment of apoptolidin A.
Diels–Alder reaction, zwitterion formation, allylation). For instance, dienes 70 and allylsilane 71 react
with SO2/CH2Cl2/Tf2NSiMe3 (cat.) at –78 °C producing 72 after work-up with Et3NH+TfO– in MeOH
(Scheme 10). This induces retro-ene eliminations of SO2 from β,γ-unsaturated sulfinic acid intermedi-
ates (see Scheme 2). SN2' Substitution of allyl acetates 72 with (Me2PhSi)2Cu(CN)Li2 generates allyl-
silanes that can be reacted again with 1,3-dioxy-1,3-dienes and SO2 to produce long-chain polyketide
fragments of type 73. The same compound 73b has been obtained in 34 % yield by reacting 2.5 equiv
of diene 70b with 74 (Scheme 11). Treatment of ent-73b with MeLi⋅LiBr in ether at –78 °C generates
a diethyl ketone (87 %) which is converted into the bis-enoxysilane 75 (76 %), the oxidation of which
with IBX⋅MPO complex [167] (IBX = idooxybenzoic acid; MPO = 4-methoxypyridine-N-oxide) gives
P. VOGEL et al.
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Scheme 10 Stereoselective double-chain elongation through two successive hetero-Diels–Alder/allylation/retro-
ene desulfinylation cascades.
Scheme 11
76 in 55 % yield. Work is underway to improve yields of the reaction sequence 74 → 73 → 75 → 76,
to desymmetrize 76 and to convert it into long-chain polyketides of natural products of biological in-
terest. In preliminary studies we have found that the double adduct of PhSH to 76 can be reduced stere-
oselectively with catecholborane and the CBS catalyst B-Me-(S)-CBS [168–171] giving 77 in 58 %
yield. Using a 1:1 mixture of 74 and ent-70b, a 55 % yield of 78 is obtained. It is converted into ethyl
ketone 79, then Nicolaou’s oxidation gives the corresponding enone that is reduced with CBS catalyst
into an allyl alcohol that is protected as paramethoxybenzyl ether 80. This compound undergoes
Sakurai’s allylation of aldehydes. For instance, with aldehyde 81, allylic alcohol 82 is formed as major
product.
CONCLUSION
The unstable sultines resulting from the hetero-Diels–Alder addition of SO2 to 1-oxy and 1,3-dioxy-
1,3-dienes are useful intermediates for the stereoselective synthesis of polyketide and polypropionate
antibiotics. Using enantiomerically enriched 1-(1-phenylethyloxy)-1,3-dienes, enantiomerically pure
sultine intermediates are formed that can be reacted with enoxysilanes or allylsilanes, in the presence
of an acid catalyst. This produces β,γ-unsaturated silyl sulfinates that can be desulfinylated into poly-
ketide or polypropionate fragments containing up to three stereogenic centers and on (E)-alkene units.
The extremities of these fragments do not require deprotection and/or functional activation and can be
used as such in all kinds of cross-aldol reactions, thus allowing the rapid construction of long-chain
polypropionates. The efficiency of the method has been demonstrated by the total asymmetric synthe-
ses of the cyclohexane subunits of baconipyrones A and B, of the Kishi’s stereoheptads of rifamycin S,
of the Nicolaou’s C1–C11 fragment of apoptolidin A, and of the Koert’s C16–C28 polyketide fragments
of the same target. At this moment, stereotriad with α,β,γ-syn,anti-relative configuration have been ob-
tained. Work is underway to develop conditions permitting the one-pot synthesis of the other stere-
omers. Combining the intermediates β,γ-unsaturated sulfinates resulting from our reaction cascade
(hetero-Diels–Alder addition of SO2, ionization of the sultine into zwitterionic species, and their
quenching by enoxysilane or allylsilanes) with electrophiles has allowed one to propose efficient, one-
pot, four-component syntheses of polyfunctionnal sulfones. By converting them into sulfonyl chloride
intermediates, one-pot, four component syntheses of polyfunctional sulfonamides are possible.
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